TY - JOUR
T1 - Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer
T2 - Results from the quality of life in motion study
AU - Braam, K. I.
AU - van Dijk-Lokkart, E. M.
AU - van Dongen, J. M.
AU - van Litsenburg, R. R.L.
AU - Takken, T.
AU - Huisman, J.
AU - Merks, J. H.M.
AU - Bosmans, J. E.
AU - Hakkenbrak, N. A.G.
AU - Bierings, M. B.
AU - van den Heuvel-Eibrink, M. M.
AU - Veening, M. A.
AU - van Dulmen-den Broeder, E.
AU - Kaspers, G. J.L.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - This study was performed to estimate the cost-effectiveness of a combined physical exercise and psychosocial intervention for children with cancer compared with usual care. Sixty-eight children, aged 8–18 years old, during or within the first year post-cancer treatment were randomised to the intervention (n = 30) and control group (n = 38). Health outcomes included fitness, muscle strength and quality adjusted life years; all administered at baseline, 4- and 12-month follow-up. Costs were gathered by 1 monthly cost questionnaires over 12 months, supplemented by medication data obtained from pharmacies. Results showed no significant differences in costs and effects between the intervention and control group at 12-month follow-up. On average, societal costs were €299 higher in the intervention group than in the control group, but this difference was not significant. Cost-effectiveness acceptability curves indicated that the intervention needs large societal investments to reach reasonable probabilities of cost-effectiveness for quality of life and lower body muscle strength. Based on the results of this study, the intervention is not cost-effective in comparison with usual care.
AB - This study was performed to estimate the cost-effectiveness of a combined physical exercise and psychosocial intervention for children with cancer compared with usual care. Sixty-eight children, aged 8–18 years old, during or within the first year post-cancer treatment were randomised to the intervention (n = 30) and control group (n = 38). Health outcomes included fitness, muscle strength and quality adjusted life years; all administered at baseline, 4- and 12-month follow-up. Costs were gathered by 1 monthly cost questionnaires over 12 months, supplemented by medication data obtained from pharmacies. Results showed no significant differences in costs and effects between the intervention and control group at 12-month follow-up. On average, societal costs were €299 higher in the intervention group than in the control group, but this difference was not significant. Cost-effectiveness acceptability curves indicated that the intervention needs large societal investments to reach reasonable probabilities of cost-effectiveness for quality of life and lower body muscle strength. Based on the results of this study, the intervention is not cost-effective in comparison with usual care.
KW - childhood cancer
KW - cost-effectiveness
KW - exercise
KW - psychosocial intervention
UR - http://www.scopus.com/inward/record.url?scp=84991063101&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/ecc.12586
DO - https://doi.org/10.1111/ecc.12586
M3 - Article
C2 - 27726229
SN - 0961-5423
VL - 26
SP - e12586
JO - European journal of cancer care
JF - European journal of cancer care
IS - 6
M1 - e12586
ER -